X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs SANOFI INDIA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER SANOFI INDIA PFIZER/
SANOFI INDIA
 
P/E (TTM) x 31.0 33.7 92.1% View Chart
P/BV x 4.9 6.4 76.9% View Chart
Dividend Yield % 0.7 1.4 46.7%  

Financials

 PFIZER   SANOFI INDIA
EQUITY SHARE DATA
    PFIZER
Mar-16
SANOFI INDIA
Dec-16
PFIZER/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs2,7244,560 59.7%   
Low Rs1,6114,400 36.6%   
Sales per share (Unadj.) Rs440.91,028.5 42.9%  
Earnings per share (Unadj.) Rs48.7129.0 37.8%  
Cash flow per share (Unadj.) Rs75.8186.0 40.7%  
Dividends per share (Unadj.) Rs15.0068.00 22.1%  
Dividend yield (eoy) %0.71.5 45.6%  
Book value per share (Unadj.) Rs462.9753.6 61.4%  
Shares outstanding (eoy) m45.7523.03 198.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.94.4 112.9%   
Avg P/E ratio x44.534.7 128.1%  
P/CF ratio (eoy) x28.624.1 118.8%  
Price / Book Value ratio x4.75.9 78.8%  
Dividend payout %30.852.7 58.4%   
Avg Mkt Cap Rs m99,163103,174 96.1%   
No. of employees `0002.93.6 79.7%   
Total wages/salary Rs m2,7583,592 76.8%   
Avg. sales/employee Rs Th6,981.76,537.7 106.8%   
Avg. wages/employee Rs Th954.5991.4 96.3%   
Avg. net profit/employee Rs Th771.1819.8 94.1%   
INCOME DATA
Net Sales Rs m20,17023,686 85.2%  
Other income Rs m857708 121.1%   
Total revenues Rs m21,02824,394 86.2%   
Gross profit Rs m4,3105,281 81.6%  
Depreciation Rs m1,2391,313 94.3%   
Interest Rs m515 34.7%   
Profit before tax Rs m3,9234,661 84.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,7941,691 106.1%   
Profit after tax Rs m2,2282,970 75.0%  
Gross profit margin %21.422.3 95.8%  
Effective tax rate %45.736.3 126.1%   
Net profit margin %11.012.5 88.1%  
BALANCE SHEET DATA
Current assets Rs m16,29915,673 104.0%   
Current liabilities Rs m7,5946,678 113.7%   
Net working cap to sales %43.238.0 113.6%  
Current ratio x2.12.3 91.5%  
Inventory Days Days6576 85.9%  
Debtors Days Days2622 115.4%  
Net fixed assets Rs m8,6228,098 106.5%   
Share capital Rs m458230 198.7%   
"Free" reserves Rs m20,72217,088 121.3%   
Net worth Rs m21,18017,356 122.0%   
Long term debt Rs m250-   
Total assets Rs m29,13725,400 114.7%  
Interest coverage x755.5311.7 242.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.9 74.2%   
Return on assets %7.711.8 65.2%  
Return on equity %10.517.1 61.5%  
Return on capital %19.026.9 70.5%  
Exports to sales %0.124.5 0.2%   
Imports to sales %17.528.0 62.5%   
Exports (fob) Rs m125,801 0.2%   
Imports (cif) Rs m3,5266,627 53.2%   
Fx inflow Rs m527,145 0.7%   
Fx outflow Rs m1406,846 2.0%   
Net fx Rs m-88299 -29.5%   
CASH FLOW
From Operations Rs m3,4363,226 106.5%  
From Investments Rs m-6,991-1,555 449.6%  
From Financial Activity Rs m-619-1,818 34.0%  
Net Cashflow Rs m-4,174-147 2,839.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 60.4 105.8%  
Indian inst/Mut Fund % 7.5 14.4 52.1%  
FIIs % 4.9 14.6 33.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 10.5 225.7%  
Shareholders   85,207 15,184 561.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  TORRENT PHARMA  PLETHICO PHARMA  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Mr Modi Providing Impetus to Defense Industry and Key Stocks in Action Today(Pre-Open)

Addressing the Uttar Pradesh Investors Summit, Mr. Modi announced the creation of a defense industrial corridor in Bundelkhand.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Feb 21, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS